1Roderick H. J. Houwen,Hans Scheffer,Gerard J. Meerman,Pieter Vlies,Charles H. C. M. Buys. Close linkage of the Wilsons’s disease locus to D13S12 in the chromosomal region 13q21 and not to ESD in 13q14[J] 1990,Human Genetics(5):560～562
4Ala A, Walker AP, Ashkan K, et al. Wilson's disease [J].Lancet, 2007,369: 397-408.
5Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease[J]. Q J Med,1993,86(3) :197-204.
6Glass JD, Reich SG, DeLong MR. Wilson's disease, development of neurological disease after beginning penieillamine therapy[J].Arch Neurol, 1990,47(5) :595-596.
7Owen CA,JR. Randall RV, Goldstein NP. Effect of dietary D-penicillamine on metabolism of copper in the rat [J]. Am J Physiol, 1975,228(1) :88-91.
8Stuerenburg HJ. CSF copper concentrations, blood-brain bar rier function, and coeruloplasmin synthesis during the treat ment of Wilson's disease[J]. J Neural Transm, 2000,107 (3) 321-329.
9Brewer GJ, Hedera P, Kluin KJ,et al. Treatment of Wilson disease with ammonium tetrathiomolybdate Ⅲ. Initial therapy in a total of 55 neurologically affected patients and follow-up with Zinc therapy [J]. Arch Neurol, 2003,60(3),379-385.
10Gollan JL, Sonay Hussein, Hoffbrand AV, et al. Red cell aplasia following prolonged D-penicillamine therapy[J].J Clin Pathol,1976, 29(2) :135-139.
